Page 17 - Richard Wyse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Richard wyse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Richard Wyse Today - Breaking & Trending Today

Rickmansworth Parkinson's cure researcher made MBE

Rickmansworth Parkinson's cure researcher made MBE
watfordobserver.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from watfordobserver.co.uk Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , Richard Kenneth Howard Wyse , Richard Wyse , Cure Parkinson , British Empire , New Year Honours , Watford Observer ,

Who's Moving: Amnesty International UK, London's Air Ambulance Charity and more

Who's Moving: Amnesty International UK, London's Air Ambulance Charity and more
civilsociety.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from civilsociety.co.uk Daily Mail and Mail on Sunday newspapers.

United Kingdom General , United Kingdom , City Of , Simon Stott , Xavier Brice , Richard Wyse , Mo Isap , Salah Mirza , Jayne Clarke , Mark Winder , Sacha Deshmukh , Anna Rose Barker , Florence Akende , Sen Raj , Weber Shandwick , Lynne Berry , Julie Harkness , Moray Macdonald , Jonathan Jenkins , Gabin Sinclair Constance , Ofei Kwafo Akoto , Gary Fraser , Maggie Aderin Pocock , Anne Marie Imafidon , Aniela Shuckburgh , Jackie Newell ,

AbFero Pharmaceuticals Announces Funding From Cure Parkinson's For Lead Compound SP-420


AbFero Pharmaceuticals Announces Funding From Cure Parkinson s For Lead Compound SP-420
Second Parkinson s Grant to Clinical Stage Pharmaceutical Company Developing Iron Chelators
HARWELL, England, Feb. 17, 2021 /PRNewswire/ AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the award of a grant from Cure Parkinson s for the development of their lead, brain-penetrant iron chelating agent, SP-420, as a disease modifying therapy for Parkinson s disease (PD).
The funding will be used to develop biomarkers to demonstrate that SP-420 is an effective targeted therapy for Parkinson s. This is the second grant AbFero has received to support development of SP-420 for the condition, following recent funding from Eureka EUROSTARS. ....

United Kingdom , Kostenloser Wertpapierhandel , Thomas Neenan , Richard Wyse , David Devos , Raymond Bergeron , University Of Lille , Research Development At Cure Parkinson , University Of Florida , Abfero Pharmaceuticals Inc , Prnewswire Abfero Ltd , Abfero Ltd , Second Parkinson , Fero Ltd , Abfero Pharmaceuticals , Cure Parkinson , Professor David Devos , Professor Raymond Bergeron , Media Contact , ஒன்றுபட்டது கிஂக்டம் , தாமஸ் நீநன் , டேவிட் டேவோஸ் , ரேமஂட் பெர்கெரான் , பல்கலைக்கழகம் ஆஃப் லில்லி , ஆராய்ச்சி வளர்ச்சி இல் குணப்படுத்த பார்கின்சன் , பல்கலைக்கழகம் ஆஃப் புளோரிடா ,